Drug Discovery's Next Blue Ocean | Ordaos Bio CEO David Longo

In this episode of The Healthcare Theory, we sit down with David Longo, co-founder and CEO of Ordaos Bio, a drug company using AI to accelerate the reduction of disease burden.David shares his unconventional journey from computational mathematics to biotech entrepreneurship, and how Ordaos is using AI to design mini-proteins that accelerate the drug development process. We delve into the inefficiencies of traditional drug discovery, the shift toward drug design, and how AI is reducing the time it takes to bring life-saving therapies to patients. David also shares insights on overcoming skepticism in the pharma industry and the exciting future of AI in healthcare. Tune in to learn how Ordaos Bio is changing the game in biotech through innovation and first-principles thinking.